Literature DB >> 24292941

AISAIC: a software suite for accurate identification of significant aberrations in cancers.

Bai Zhang1, Xuchu Hou, Xiguo Yuan, Ie-Ming Shih, Zhen Zhang, Robert Clarke, Roger R Wang, Yi Fu, Subha Madhavan, Yue Wang, Guoqiang Yu.   

Abstract

UNLABELLED: Accurate identification of significant aberrations in cancers (AISAIC) is a systematic effort to discover potential cancer-driving genes such as oncogenes and tumor suppressors. Two major confounding factors against this goal are the normal cell contamination and random background aberrations in tumor samples. We describe a Java AISAIC package that provides comprehensive analytic functions and graphic user interface for integrating two statistically principled in silico approaches to address the aforementioned challenges in DNA copy number analyses. In addition, the package provides a command-line interface for users with scripting and programming needs to incorporate or extend AISAIC to their customized analysis pipelines. This open-source multiplatform software offers several attractive features: (i) it implements a user friendly complete pipeline from processing raw data to reporting analytic results; (ii) it detects deletion types directly from copy number signals using a Bayes hypothesis test; (iii) it estimates the fraction of normal contamination for each sample; (iv) it produces unbiased null distribution of random background alterations by iterative aberration-exclusive permutations; and (v) it identifies significant consensus regions and the percentage of homozygous/hemizygous deletions across multiple samples. AISAIC also provides users with a parallel computing option to leverage ubiquitous multicore machines.
AVAILABILITY AND IMPLEMENTATION: AISAIC is available as a Java application, with a user's guide and source code, at https://code.google.com/p/aisaic/.

Entities:  

Mesh:

Year:  2013        PMID: 24292941      PMCID: PMC3904524          DOI: 10.1093/bioinformatics/btt693

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  5 in total

1.  BACOM: in silico detection of genomic deletion types and correction of normal cell contamination in copy number data.

Authors:  Guoqiang Yu; Bai Zhang; G Steven Bova; Jianfeng Xu; Ie-Ming Shih; Yue Wang
Journal:  Bioinformatics       Date:  2011-04-15       Impact factor: 6.937

2.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

3.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

4.  Genome-wide identification of significant aberrations in cancer genome.

Authors:  Xiguo Yuan; Guoqiang Yu; Xuchu Hou; Ie-Ming Shih; Robert Clarke; Junying Zhang; Eric P Hoffman; Roger R Wang; Zhen Zhang; Yue Wang
Journal:  BMC Genomics       Date:  2012-07-27       Impact factor: 3.969

5.  High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring.

Authors:  Sonia de Assis; Anni Warri; M Idalia Cruz; Olusola Laja; Ye Tian; Bai Zhang; Yue Wang; Tim Hui-Ming Huang; Leena Hilakivi-Clarke
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

  5 in total
  4 in total

1.  BACOM2.0 facilitates absolute normalization and quantification of somatic copy number alterations in heterogeneous tumor.

Authors:  Yi Fu; Guoqiang Yu; Douglas A Levine; Niya Wang; Ie-Ming Shih; Zhen Zhang; Robert Clarke; Yue Wang
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

2.  Accurate Inference of Tumor Purity and Absolute Copy Numbers From High-Throughput Sequencing Data.

Authors:  Xiguo Yuan; Zhe Li; Haiyong Zhao; Jun Bai; Junying Zhang
Journal:  Front Genet       Date:  2020-04-30       Impact factor: 4.599

3.  Obtaining spatially resolved tumor purity maps using deep multiple instance learning in a pan-cancer study.

Authors:  Mustafa Umit Oner; Jianbin Chen; Egor Revkov; Anne James; Seow Ye Heng; Arife Neslihan Kaya; Jacob Josiah Santiago Alvarez; Angela Takano; Xin Min Cheng; Tony Kiat Hon Lim; Daniel Shao Weng Tan; Weiwei Zhai; Anders Jacobsen Skanderup; Wing-Kin Sung; Hwee Kuan Lee
Journal:  Patterns (N Y)       Date:  2021-12-09

4.  Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring.

Authors:  Raquel Santana da Cruz; Elissa J Carney; Johan Clarke; Hong Cao; M Idalia Cruz; Carlos Benitez; Lu Jin; Yi Fu; Zuolin Cheng; Yue Wang; Sonia de Assis
Journal:  Breast Cancer Res       Date:  2018-08-30       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.